Register for the webinar here: https://bit.ly/WashUniv

Learn how ChipCytometry can unlock meaningful discoveries:

Immune cell profiling is a key part of characterizing the complexities of cancer biology to develop and commercialize new therapy options.

ChipCytometry allows for the quantitative analysis of virtually unlimited protein biomarkers in a single sample for deep immune cell phenotyping. The technology combines high-resolution HDR imaging & AI-powered cell-segmentation software to deliver quantitative biomarker analysis with true single-cell resolution, enabling deep phenotyping of every individual cell in your sample. ChipCytometry has broad applications to clinical and pre-clinical studies in oncology, immunology, and drug development.

For inquiries contact Amy Johnson.